Antiulcerant Drugs to Escalate in Emerging Markets to 2022

NEXT STORY
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
PREV STORY
Nova Scotia Exports Mental Health Resources
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Eurobio Scientific reaches the €50M sales mark in 2018

EUROBIO SCIENTIFIC REACHES THE €50M SALES MARK IN 2018 Eurobio Scientific consolidated sales reached ...

author_avatar
NASDAQ Market News

Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®

PARSIPPANY, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

author_avatar
NASDAQ Market News

ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress

MOUNTAIN VIEW, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), today announced ...

author_avatar
NASDAQ Market News